SCHEMBL238282

SCHEMBL238282

CCCCCCCC/C=C\CCCCCCCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.84

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CETP P11597 1/20 0.63
MAPK1 P28482 1/20 0.57
LGALS8 O00214 1/20 0.53
LGALS3 P17931 1/20 0.53
LGALS4 P56470 1/20 0.53
GJB2 P29033 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13641399 1.00 CETP (0.63) CETPMAPK1LGALS8LGALS3LGALS4
SCHEMBL14670338 1.00 CETP (0.63) CETPMAPK1LGALS8LGALS3LGALS4
SCHEMBL8577943 1.00 CETP (0.63) CETPMAPK1LGALS8LGALS3LGALS4
SCHEMBL1704586 1.00 CETP (0.63) CETPMAPK1LGALS8LGALS3LGALS4
SCHEMBL1704479 1.00 CETP (0.63) CETPMAPK1LGALS8LGALS3LGALS4
SCHEMBL1705072 1.00 CETP (0.63) CETPMAPK1LGALS8LGALS3LGALS4
SCHEMBL1704659 1.00 CETP (0.63) CETPMAPK1LGALS8LGALS3LGALS4
SCHEMBL1704977 1.00 CETP (0.63) CETPMAPK1LGALS8LGALS3LGALS4
SCHEMBL18074796 1.00 CETP (0.63) CETPMAPK1LGALS8LGALS3LGALS4
SCHEMBL1705285 1.00 CETP (0.63) CETPMAPK1LGALS8LGALS3LGALS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117802556-A Ni-Mo-TiN composite coating and preparation method thereof 暨南大学 2024-04-02 CN claimed
EP-1093801-B1 W/O-emulsion and its use especially in cosmetics OREAL (FR) 2004-06-02 EP claimed
US-20030108579-A1 Topical composition L'OREAL (FR) 2003-06-12 US claimed
EP-1097695-B1 Composition containing an aqueous suspension of particles of an organopolysiloxane elastomer and cosmetical uses thereof OREAL (FR) 2002-09-18 EP claimed
US-6335025-B1 ALKYLPOLYGLYCOSIDE AND VOLATILE OIL; STABILITY, FRESHNESS; USED FOR SKIN, NAILS, HAIR L'OREAL (FR) 2002-01-01 US claimed
EP-0425643-A1 OCTADIENYL ETHERS AND A PROCESS FOR MAKING OCTADIENYL ETHERS. HENKEL RESEARCH CORP (US) 1991-05-08 EP claimed
WO-1990013531-A2 OCTADIENYL ETHERS AND A PROCESS FOR MAKING OCTADIENYL ETHERS HENKEL RESEARCH CORPORATION (US) 1990-11-15 WO claimed
EP-4398868-A1 AN ORAL CARE COMPOSITION COMPRISING A GLYCOLIPID AND A MILD SURFACTANT BASF SE (DE) 2024-07-17 EP disclosed
CN-118234476-A Oral care compositions comprising glycolipids and mild surfactants 巴斯夫欧洲公司 2024-06-21 CN disclosed
CN-117802556-A Ni-Mo-TiN composite coating and preparation method thereof 暨南大学 2024-04-02 CN disclosed
CN-117597102-A Sun protection W/O emulsion 莱雅公司 2024-02-23 CN disclosed
US-20240041715-A1 PROCESS FOR TREATING HUMAN PERSPIRATION AND BODY ODORS USING MAGNESIUM OXIDE AND A PHOSPHATE SALT L'OREAL (FR) 2024-02-08 US disclosed
CN-117396179-A Electroporation method for delivering a composition comprising at least one peptide having a molecular weight of 500Da to 20kDa 欧莱雅 2024-01-12 CN disclosed
US-5429820-A A POLYOL GLYCERYL ETHER WHICH PROVIDES MOISTURIZING EFFECTS AND EXTENSIBILITY TO COSMETICS KAO CORPORATION (JP) 1995-07-04 US disclosed
EP-0553241-B1 USE OF FATTY ALCOHOL BASED COMPOSITIONS FOR PREPARING EMULSIONS, METHOD OF PREPARING EMULSIONS AND EMULSIONS SO OBTAINED SEPPIC SA (FR) 1995-04-12 EP disclosed
EP-0553241-A1 USE OF FATTY ALCOHOL BASED COMPOSITIONS FOR PREPARING EMULSIONS, METHOD OF PREPARING EMULSIONS AND EMULSIONS SO OBTAINED. DE PRODUITS POUR LES IND CHIMI (FR) 1993-08-04 EP disclosed
EP-0512270-A2 Cosmetic composition KAO CORPORATION (JP) 1992-11-11 EP disclosed
WO-1992006778-A1 USE OF FATTY ALCOHOL BASED COMPOSITIONS FOR PREPARING EMULSIONS, METHOD OF PREPARING EMULSIONS AND EMULSIONS SO OBTAINED SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES (S.E.P.P.I.C.) (FR) 1992-04-30 WO disclosed
EP-0425643-A1 OCTADIENYL ETHERS AND A PROCESS FOR MAKING OCTADIENYL ETHERS. HENKEL RESEARCH CORP (US) 1991-05-08 EP disclosed
WO-1990013531-A2 OCTADIENYL ETHERS AND A PROCESS FOR MAKING OCTADIENYL ETHERS HENKEL RESEARCH CORPORATION (US) 1990-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240041715-A1 PROCESS FOR TREATING HUMAN PERSPIRATION AND BODY ODORS USING MAGNESIUM OXIDE AND A PHOSPHATE SALT TRPM5, TRPM6, MSH6 CETP 637/4885MAPK1 814/4885LGALS8 2812/4885
US-20030108579-A1 Topical composition CUTA, EBP, TSLP CETP 27/4885MAPK1 4334/4885LGALS8 949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.